← All stocks

DAXOR CORP

DXR Net buying

CIK 0000027367 #4624 in the set updated 21 Sep 2026

Bought (120 mo)

$1.77M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$1.41M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$1.41M

5 of 5 sales

Net

+$364.33K

+$364.33K against sales at will

By person

10 insiders · 53 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

FELDSCHUH JOSEPH

10% owner

$1.46M (1)

$650.53K (2)

+$811.47K

2,774,455

$25.16M

+3.2%

Feldschuh Jonathan Adam

Chief Scientific Officer

— (2)

$357.58K (1)

−$357.58K

78,908

$715.70K

+241.6%

Feldschuh Michael Richard

Chief Executive Officer

$167.25K (23)

$341.12K (1)

−$173.87K

243,694

$2.21M

+153.5%

Michel Robert J

Chief Financial Officer

$83.80K (13)

—

+$83.80K

33,050

$299.76K

—

Thompson Soren

VP, Business Development

$8.75K (2)

$57.63K (1)

−$48.88K

1,950

$17.69K

−63.9%

DesRosiers Caleb

Director

$29.99K (1)

—

+$29.99K

3,157

$28.63K

—

Feuer Edward

Director

$16.48K (2)

—

+$16.48K

1,000

$9.07K

—

Goudie Joy S.

Director

$2.93K (1)

—

+$2.93K

300

$2.72K

—

Jefferies John

Chief Medical Officer

— (3)

—

$0.00

26,008

$235.89K

+70.3%

Estate of Joseph Feldschuh entity

10% owner

—

2,549,455

$23.12M

−8.9%

No percentages here. DAXOR CORP reports its share count only per share class, which the XBRL frames API does not carry.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 93

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 5

Transactions with no price 0

Shares from compensation/vesting 399,435

Sales filed before the plan box existed 5

History held since 9 Jan 2017